Previous studies showed that elevated E-cadherin expressioncan suppress epithelial tumor cell invasiveness, whereas reducedE-cadherin levels correlate with more aggressive tumor stages and poor clinicaloutcome17, 18. Here, CDH17 is linked to neoplasm.